Maverick Capital’s Boston Scientific BSX Stock Holding History

Maverick Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$253M	Buy	5,937,553 +1,742,464	+42%	+$94.6M	2.24%	19
2026 Q1	$263M	Buy	4,195,089 +1,250,835	+42%	+$100M	3.04%	9
2025 Q4	$281M	Buy	+2,944,254	New	+$289M	3.01%	10
2024 Q2	–	Sell	-5,748	Closed	-$394K	–	295
2024 Q1	$394K	Sell	5,748 -3,083	-35%	-$198K	0.01%	278
2023 Q4	$511K	Buy	+8,831	New	+$471K	0.01%	187
2021 Q4	–	Sell	-62,528	Closed	-$2.71M	–	361
2021 Q3	$2.71M	Sell	62,528 -32,668	-34%	-$1.45M	0.03%	146
2021 Q2	$4.07M	Buy	95,196 +62,070	+187%	+$2.61M	0.04%	108
2021 Q1	$1.28M	Sell	33,126 -36,915	-53%	-$1.4M	0.01%	206
2020 Q4	$2.52M	Buy	70,041 +5,745	+9%	+$207K	0.04%	109
2020 Q3	$2.46M	Buy	+64,296	New	+$2.48M	0.05%	114
2019 Q1	–	Sell	-77,730	Closed	-$2.75M	–	281
2018 Q4	$2.75M	Buy	+77,730	New	+$2.82M	0.04%	230
2018 Q2	–	Sell	-71,740	Closed	-$1.96M	–	250
2018 Q1	$1.96M	Buy	+71,740	New	+$1.95M	0.03%	194

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Maverick Capital's BSX Position: Q2 2026 in Review

Maverick Capital increased its Boston Scientific (BSX) stake by 42% in Q2 2026, buying an estimated $94.6M and bringing the position to 5,937,553 shares worth $253M. The position accounts for 2.24% of the portfolio, ranked #19.

Maverick Capital first reported a position in BSX in Q1 2018 and has held it in 12 quarters since. The position peaked at $281M in Q4 2025. 1,473 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Maverick Capital held 5,937,553 shares of Boston Scientific worth $253M as of Q2 2026.
Maverick Capital bought 1,742,464 Boston Scientific shares in Q2 2026, an estimated $94.6M.
Boston Scientific made up 2.24% of Maverick Capital's portfolio in Q2 2026, its #19 holding.
Maverick Capital first reported a position in Boston Scientific in Q1 2018 and has held it in 12 quarters since.
Maverick Capital's Boston Scientific position peaked at $281M in Q4 2025.
1,473 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Maverick Capital's 13F filing for Q2 2026, filed 14 Aug 2026.